Innovaderm continues use of Medrio’s EDC for dermatology trials

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/	Hoxton/Tom Merton)
(Image: Getty/ Hoxton/Tom Merton)

Related tags: Edc, Clinical trials, Clinical research, Data management, Dermatology, Software, eclinical

Innovaderm inks deal to extend its use of Medrio’s cloud-based EDC technology for early-phase dermatology clinical trials through 2023.

The specialty contract research organization (CRO) focused on dermatology, Innovaderm, has been a client of Medrio eClinical software for over 9 years, using its software in Phase I, IIa, and IIb studies.  

The new agreement will see Innovaderm continue its use of Medrio’s eClinical software platforms, including: eSource, eConsent, and ePro, until 2023.

All of these eClinical software platforms are designed for the use in early-phase pharma clinical research, and  include electronic data capture (EDC), which Innovaderm cited as part of the reason for continuing the partnership. “Organizations conducting all types of clinical trials use EDC to build study databases, store data electronically, detect and resolve data entry errors, run reports on their data, and more. The reason Medrio is particularly well-suited to early phase pharma trials has to do with simplicity and cost,”​ a company spokesperson told us.

The spokesperson explained that a platform with cloud-based EDC is a fit for early phase trials due to the needs of those studies, “Early phase trials typically use more straightforward study designs and often require mid-study changes to the database, and this goes hand-in-hand with Medrio enabling users to build studies on their own without any programming, which many other EDCs require, and easily make mid-study changes on the fly.”

Medrio’s eConsent was added to the company’s eClinical software platform in November 2018 as a way to provide clients with an electronic-consent application​ to accelerate clinical trial processes. The cloud-based platform enables sponsors and CROs to access consent forms instantly. 

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars